Jürgen Siepmann

Contact Details

University of Lille

College of Pharmacy, Inserm U1008

3, rue du Professeur Laguesse

59000 Lille, France


Tel.: +33 (0)3 20 96 47 08

Email: juergen.siepmann@univ-lille.fr


Short CV

Juergen Siepmann studied Pharmacy and did his Ph.D. at the Freie Universitaet Berlin, Germany. Since 2004 he is Professor of Pharmaceutical Technology at the University of Lille, France. His awards include the “APV-Prize for the outstanding doctoral thesis in Pharmaceutical Sciences from the years 1998/99”, a Marie Curie Individual Post-Doctoral Fellowship, the “2012 APV Research Award for Outstanding Achievements in the Pharmaceutical Sciences” and the “Highly Cited Researchers 2021” award (Clarivate). He was visiting scientist/postdoctoral fellow at Purdue University, the University of Paris-Sud, University of Iowa and University of Angers. Prof. Siepmann’s research focuses on controlled drug delivery systems, in particular on the elucidation of the underlying mass transport phenomena, mathematical modeling and the optimization of the devices. So far, he published his work in about 200 articles in international scientific journals, 350 poster and 150 oral presentations at national and international scientific meetings. He is editor of 3 books, theme editor of 10 special issues, inventor of 9 patents and author of 17 book chapters. In 2010, Prof. Siepmann created the INSERM research group “Controlled Drug Delivery Systems and Biomaterials” (INSERM = French National Institute of Health and Medical Research), currently counting about 50 staff members (9 professors, 6 lecturers, 5 technical/administrative staff, 20 post-docs & PhD students and 10 master students). In 2015, Prof. Siepmann served as Editor-in-Chief of the “Journal of Drug Delivery Sciences and Technology”. Since 2016 he serves as the Editor-in-Chief of the “International Journal of Pharmaceutics”, since 2019 also of the gold open access companion journal “International Journal of Pharmaceutics: X”. Since 2010 he serves as president of the APGI (“International Society of Drug Delivery Sciences and Technology”). (June 2022)